<DOC>
	<DOCNO>NCT02759224</DOCNO>
	<brief_summary>An Open-Label , Randomized , Single-dose , 2x2 Crossover Study Compare Pharmacokinetics BRI-1501 Tablet Coadministration Lafutidine Irsogladine maleate Individual Tablets Healthy Adult Volunteers</brief_summary>
	<brief_title>A Study Compare Pharmacokinetics Lafutidine Irsogladine Maleate Tablet</brief_title>
	<detailed_description />
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Lafutidine</mesh_term>
	<mesh_term>Irsogladine</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>Healthy subject , age 19 50 year History clinically significant active disease History gastrointestinal disease History clinically significant hypersensitivity study drug , drug Laboratory test serum AST ALT &gt; 1.25 time upper normal range serum total bilirubin &gt; 1.5 time upper normal range eGFR &lt; 60 ml/min/1.73mÂ² serological test ( HBsAg , HCV Ab , HIV Ag/Ab , Syphilis reagin ) positive Hypotension hypertension Pregnant nursing woman Participation study within 90 day</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>